The Czech Experience in Peritonectomy and Hyperthermic Perioperative Cytostatic Lavage in the Treatment of Peritoneal Malignancy;Die Tschechische Erfahrung mit der Peritonektomie und Hyperthermen Perioperativen Zytostatikalavage in der Behandlung der Peritonealkarzinose

Zentralblatt fur Chirurgie

Volumn 129, Issue 2, 2004, Pages 153-156

  Antos, Frantisek ^a,b   Serclova, Z ^a   Gilbert, Z ^a   Skala, M ^a   Vitek, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

Author keywords

Hyperthermic perioperative cytostatic lavage; Peritoneal carcinomatosis; Peritonectomy

Indexed keywords

CARBOPLATIN; CISPLATIN; ELECTROLYTE; MITOMYCIN C;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTHERMIA; HYPERTHERMIC THERAPY; MALE; MORBIDITY; PERFUSION; PERIOPERATIVE PERIOD; PERITONEUM LAVAGE; PERITONEUM METASTASIS; SURGICAL MORTALITY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COMBINED MODALITY THERAPY; CZECH REPUBLIC; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; PERITONEAL LAVAGE; PERITONEAL NEOPLASMS; PERITONEUM; SURVIVAL RATE;

EID: 1942504070     PISSN: 0044409X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-818764     Document Type: Article

References (10)

1. Ceelen WP, Hesse U, de Hamptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intraabdominal cancer. Br J Surg 2000; 87: 1006-1015
2. Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E. Feasibilty of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with pseudomyxoma peritonel. Tumori 2002; 88: 370-375
3. Hinson FL, Ambrose NS. Pseudomyxoma peritonei. Br J Surg 1998; 85: 1332-1339
4. Jacquet P, Averbach A, Stuart OA, Chang D, Sugerbaker PH. Heated intraoperative intraperitoneal Mitomycin C and early postoperative intraperitoneal 5-Fluorouracyl: Pharmacokinetic Studies. Oncology 1998; 55: 130-138
5. Pilaty P, Rossi CR, Mocellin S, Foletto, M, Scagnet B., Pasetto L, Lise M. Multimodal treatment of peritoneal carcinomatosis and sarcomatosis. EJSO 2001; 27: 126-134
6. Shepard NA, Baxter KJ, Love SB. The prognostic importance of peritoneal involvement in colonic cancer. A prospective evaluation. Gastroenterology 1997; 112: 1096-1102
7. Spratt JS, Adcock RA, Muskovin M, Sherrill W, Mc Keown J, Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980; 40: 256-260
8. Sugarbaker PH. Peritonectomy Procedures. Ann Surg 1995; 221: 29-41
9. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudmyxoma peritonei syndrome. EJSO 2001; 27: 239-243
10. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resecable rectal Cancer. N Engl J Med 1997; 336: 980-987